Published in Diabetes on December 03, 2012
The Sexual Dimorphism of Lipid Kinetics in Humans. Front Endocrinol (Lausanne) (2015) 0.86
Postprandial triglycerides and adipose tissue storage of dietary fatty acids: impact of menopause and estradiol. Obesity (Silver Spring) (2014) 0.82
Crude extracts from Lycium barbarum suppress SREBP-1c expression and prevent diet-induced fatty liver through AMPK activation. Biomed Res Int (2014) 0.80
Adipose tissue fatty acid storage factors: effects of depot, sex and fat cell size. Int J Obes (Lond) (2015) 0.80
Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape. Horm Mol Biol Clin Investig (2014) 0.77
Postnatal Treatment with Metyrapone Attenuates the Effects of Diet-Induced Obesity in Female Rats Exposed to Early Life Stress. Am J Physiol Endocrinol Metab (2016) 0.75
Acute Female Hypogonadism Alters Adipose Tissue Fatty Acid Storage Factors and Chylomicronemia. J Clin Endocrinol Metab (2016) 0.75
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol (1983) 6.45
Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64
The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab (2003) 4.55
A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res (1976) 4.38
Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res (2008) 4.09
Menopause and risk factors for coronary heart disease. N Engl J Med (1989) 3.84
Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol (1997) 3.32
Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) (2008) 3.18
Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr (1995) 2.50
Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem (2005) 2.33
Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J Biol Chem (2002) 2.25
Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr (1992) 2.23
Aging, body composition, and lifestyle: the Fels Longitudinal Study. Am J Clin Nutr (1999) 1.96
Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes (2007) 1.88
Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc (1993) 1.77
Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am J Physiol Endocrinol Metab (2000) 1.72
Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev Cell (2002) 1.67
Fallacy of per-weight and per-surface area standards, and their relation to spurious correlation. J Appl Physiol (1949) 1.64
A quick, reliable, and automated method for fat cell sizing. J Lipid Res (2003) 1.61
Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis (1993) 1.57
Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. J Biol Chem (2003) 1.56
Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab (1997) 1.54
Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidol (2007) 1.53
Assay of plasma catecholamines by liquid chromatography with electrochemical detection. Anal Biochem (1981) 1.51
The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res (2006) 1.50
Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS. J Lipid Res (2010) 1.50
Uptake of triglyceride fatty acids in adipose tissue in vivo in man. Eur J Clin Invest (1990) 1.43
Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health (2000) 1.43
How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes (1999) 1.41
Sex-specific differences in leg fat uptake are revealed with a high-fat meal. Am J Physiol Endocrinol Metab (2006) 1.25
Micro-method for measurement of sub-nanomole amounts of triacylglycerol. Ann Clin Biochem (1990) 1.21
Concerted elevation of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin. Biochem Biophys Res Commun (2002) 1.19
Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chem (2000) 1.16
Visceral and subcutaneous adipose tissue diacylglycerol acyltransferase activity in humans. Obesity (Silver Spring) (2009) 1.12
The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group. Atherosclerosis (1999) 1.09
Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukot Essent Fatty Acids (1997) 1.06
Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women. J Clin Invest (1988) 1.04
Regulation of gene expression by insulin and tumor necrosis factor alpha in 3T3-L1 cells. Modulation of the transcription of genes encoding acyl-CoA synthetase and stearoyl-CoA desaturase-1. J Biol Chem (1991) 1.04
A novel ELISA for measuring CD36 protein in human adipose tissue. J Lipid Res (2010) 1.04
Meal fatty acid uptake in human adipose tissue: technical and experimental design issues. Am J Physiol Endocrinol Metab (2000) 1.03
The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest (1998) 1.01
Effects of male hypogonadism on regional adipose tissue fatty acid storage and lipogenic proteins. PLoS One (2012) 0.98
Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas (2003) 0.95
Estrogen regulation of adipose tissue lipoprotein lipase--possible mechanism of body fat distribution. Am J Obstet Gynecol (1998) 0.91
Physiological concentrations of insulin and T3 stimulate 3T3-L1 adipocyte acyl-CoA synthetase gene transcription. Am J Physiol (1996) 0.90
Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol (1994) 0.85
Effects of postmenopausal hormone replacement therapy on body fat composition. Gynecol Endocrinol (2007) 0.84
Effect of oral estrogen on substrate utilization in postmenopausal women. Fertil Steril (2007) 0.83
Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance. Menopause (2010) 0.81
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91
DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet (2006) 6.50
Interindividual variation in posture allocation: possible role in human obesity. Science (2005) 6.26
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol (2013) 5.24
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
Splanchnic lipolysis in human obesity. J Clin Invest (2004) 3.94
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab (2006) 3.03
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71
Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes (2003) 2.53
Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) (2008) 2.23
Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol (2002) 2.23
Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A (2010) 2.17
Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2004) 2.16
Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res (2003) 1.92
Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes (2007) 1.88
Subcutaneous adipocyte size and body fat distribution. Am J Clin Nutr (2008) 1.80
Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care (2003) 1.78
Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest (2003) 1.62
A quick, reliable, and automated method for fat cell sizing. J Lipid Res (2003) 1.61
Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution. Diabetes (2011) 1.53
Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS. J Lipid Res (2010) 1.50
Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res (2006) 1.48
Acute changes in lipoprotein subclasses during exercise. Metabolism (2013) 1.45
Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans. J Physiol (2009) 1.41
Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology (2006) 1.39
Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res (2005) 1.38
Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring) (2010) 1.37
Why are we shaped differently, and why does it matter? Am J Physiol Endocrinol Metab (2008) 1.35
Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab (2010) 1.31
Fat depots, free fatty acids, and dyslipidemia. Nutrients (2013) 1.30
Sex-specific differences in leg fat uptake are revealed with a high-fat meal. Am J Physiol Endocrinol Metab (2006) 1.25
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol (2004) 1.24
Basal and insulin-regulated free fatty acid and glucose metabolism in humans. Am J Physiol Endocrinol Metab (2007) 1.24
Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J (2008) 1.24
Preventing overestimation of pixels in computed tomography assessment of visceral fat. Obes Res (2004) 1.22
Plasma free fatty acid storage in subcutaneous and visceral adipose tissue in postabsorptive women. Diabetes (2008) 1.22
Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation (2006) 1.20
Strength training and adiposity in premenopausal women: strong, healthy, and empowered study. Am J Clin Nutr (2007) 1.20
Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care (2007) 1.20
Meal fatty acid uptake in visceral fat in women. Diabetes (2007) 1.20
Leptin upregulates caveolin-1 expression: implications for development of atherosclerosis. Atherosclerosis (2010) 1.19
Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul Integr Comp Physiol (2004) 1.16
Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care (2005) 1.15
Single-gene detection and karyotyping using small-target fluorescence in situ hybridization on maize somatic chromosomes. Genetics (2007) 1.13
The influence of sex and obesity phenotype on meal fatty acid metabolism before and after weight loss. Am J Clin Nutr (2008) 1.13
Visceral and subcutaneous adipose tissue diacylglycerol acyltransferase activity in humans. Obesity (Silver Spring) (2009) 1.12
A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans. Rapid Commun Mass Spectrom (2012) 1.10
Sex differences in abdominal, gluteal, and thigh LPL activity. Am J Physiol Endocrinol Metab (2007) 1.10
Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes (2011) 1.09
Storage rates of circulating free fatty acid into adipose tissue during eating or walking in humans. Diabetes (2012) 1.07
Regional fat deposition as a factor in FFA metabolism. Annu Rev Nutr (2007) 1.07
Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am J Physiol Endocrinol Metab (2006) 1.07
Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism (2004) 1.05
Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists. Mol Neurobiol (2005) 1.04
Modest visceral fat gain causes endothelial dysfunction in healthy humans. J Am Coll Cardiol (2010) 1.04
A novel ELISA for measuring CD36 protein in human adipose tissue. J Lipid Res (2010) 1.04
Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes (2007) 1.04
Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet. Am J Physiol Endocrinol Metab (2013) 1.04
Vascular response to angiotensin II in upper body obesity. Hypertension (2004) 1.02
Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients. Eur J Endocrinol (2004) 0.99
Effects of male hypogonadism on regional adipose tissue fatty acid storage and lipogenic proteins. PLoS One (2012) 0.98
Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab (2013) 0.98
Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring) (2007) 0.97
Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer. J Lipid Res (2005) 0.95
Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance. Obesity (Silver Spring) (2012) 0.95
Measuring long-chain acyl-coenzyme A concentrations and enrichment using liquid chromatography/tandem mass spectrometry with selected reaction monitoring. Rapid Commun Mass Spectrom (2011) 0.94
Weekly changes in basal metabolic rate with eight weeks of overfeeding. Obesity (Silver Spring) (2006) 0.94
Body fat distribution, adipocyte size, and metabolic characteristics of nondiabetic adults. J Clin Endocrinol Metab (2009) 0.93
Energy expenditure, insulin, and VLDL-triglyceride production in humans. J Lipid Res (2006) 0.93
Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab (2008) 0.93
Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes (2002) 0.92
Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol (2007) 0.92
Recruitment and screening for a randomized trial investigating Roux-en-Y gastric bypass versus intensive medical management for treatment of type 2 diabetes. Obes Surg (2014) 0.91
Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes. Diabetes Care (2006) 0.91
Diet/Exercise versus pioglitazone: effects of insulin sensitization with decreasing or increasing fat mass on adipokines and inflammatory markers. J Clin Endocrinol Metab (2006) 0.91
Effects of weight gain and weight loss on regional fat distribution. Am J Clin Nutr (2012) 0.91
Fatty acid metabolism in the elderly: effects of dehydroepiandrosterone and testosterone replacement in hormonally deficient men and women. J Clin Endocrinol Metab (2009) 0.90
Comparisons of energy intake and energy expenditure in overweight and obese women with and without binge eating disorder. Obesity (Silver Spring) (2011) 0.89
Proinflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress, and dynamics. Am J Physiol Endocrinol Metab (2014) 0.88
Determination of skeletal muscle triglyceride synthesis using a single muscle biopsy. Metabolism (2002) 0.87
Treatment of obesity with diet/exercise versus pioglitazone has distinct effects on lipoprotein particle size. Atherosclerosis (2005) 0.86
Action on obesity: report of a mayo clinic national summit. Mayo Clin Proc (2005) 0.86
Impact of insulin deprivation and treatment on sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice. Am J Physiol Endocrinol Metab (2013) 0.86
Validity of weight loss to estimate improvement in body composition in individuals attending a wellness center. Obesity (Silver Spring) (2011) 0.85
Effects of exercise on VLDL-triglyceride oxidation and turnover. Am J Physiol Endocrinol Metab (2011) 0.85
Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity. Clin Gastroenterol Hepatol (2003) 0.85
Postabsorptive VLDL-TG fatty acid storage in adipose tissue in lean and obese women. Obesity (Silver Spring) (2009) 0.85
Intramyocellular diacylglycerol concentrations and [U-¹³C]palmitate isotopic enrichment measured by LC/MS/MS. J Lipid Res (2013) 0.85
Leptin-based adjuvants: an innovative approach to improve vaccine response. Vaccine (2013) 0.84
Leptin signaling in adipose tissue: role in lipid accumulation and weight gain. Circ Res (2012) 0.84
Insulin sensitivity and regional fat gain in response to overfeeding. Obesity (Silver Spring) (2010) 0.84
Free fatty acid flux in African-American and Caucasian adults--effect of sex and race. Obesity (Silver Spring) (2013) 0.83
Systemic free fatty acid disposal into very low-density lipoprotein triglycerides. Diabetes (2013) 0.83